149 related articles for article (PubMed ID: 16518915)
1. [Clinical efficacy of Actimel for patients with the irritated bowel syndrome with prevailing diarrhea].
Parfenov AI; Ruchkina IN; Tsaregorodtsev TM; Serova TI
Eksp Klin Gastroenterol; 2005; (5):45-52. PubMed ID: 16518915
[No Abstract] [Full Text] [Related]
2. Ask the doctor. I have chronic diarrhea because of irritable bowel syndrome (IBS). Should I take probiotics?
Robb-Nicholson C
Harv Womens Health Watch; 2013 Mar; 20(7):2. PubMed ID: 23862208
[No Abstract] [Full Text] [Related]
3. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.
Sohn W; Lee OY; Kwon JG; Park KS; Lim YJ; Kim TH; Jung SW; Kim JI
Neurogastroenterol Motil; 2012 Sep; 24(9):860-e398. PubMed ID: 22679908
[TBL] [Abstract][Full Text] [Related]
4. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
5. Board Review Vignette: Irritable Bowel Syndrome.
Talley NJ
Am J Gastroenterol; 2016 Sep; 111(9):1223-5. PubMed ID: 27527743
[No Abstract] [Full Text] [Related]
6. [Effectiveness of pharmacotherapy of irritated bowel syndrome from the standpoint of evidence based medicine].
Sheptulin AA; Vize-Khripunova MA
Klin Med (Mosk); 2014; 92(7):64-8. PubMed ID: 25775909
[TBL] [Abstract][Full Text] [Related]
7. Probiotic
Lai HH; Chiu CH; Kong MS; Chang CJ; Chen CC
Nutrients; 2019 May; 11(5):. PubMed ID: 31126062
[TBL] [Abstract][Full Text] [Related]
8. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
Abbas Z; Yakoob J; Jafri W; Ahmad Z; Azam Z; Usman MW; Shamim S; Islam M
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.
Zhang L; Liu YX; Wang Z; Wang XQ; Zhang JJ; Jiang RH; Wang XQ; Zhu SW; Wang K; Liu ZJ; Zhu HQ; Duan LP
Chin Med J (Engl); 2019 Feb; 132(3):346-351. PubMed ID: 30681503
[No Abstract] [Full Text] [Related]
10. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
11. Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?
Grover M; Camilleri M
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):960-2. PubMed ID: 24393804
[No Abstract] [Full Text] [Related]
12. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
13. [Probiotics as therapeutic agents in irritable bowel syndrome].
Krammer HJ; Schlieger F; Harder H; Franke A; Singer MV
Z Gastroenterol; 2005 May; 43(5):467-71. PubMed ID: 15871070
[TBL] [Abstract][Full Text] [Related]
14. Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome.
Sayuk GS
Gastroenterol Clin North Am; 2021 Sep; 50(3):611-637. PubMed ID: 34304791
[TBL] [Abstract][Full Text] [Related]
15. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
16. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
17. Probiotics and prebiotics in pediatric diarrheal disorders.
Vandenplas Y; De Greef E; Hauser B; Devreker T; Veereman-Wauters G
Expert Opin Pharmacother; 2013 Mar; 14(4):397-409. PubMed ID: 23406505
[TBL] [Abstract][Full Text] [Related]
18. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
Pimentel M
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():37-49. PubMed ID: 26618924
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.
Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):428-429. PubMed ID: 33177346
[No Abstract] [Full Text] [Related]
20. Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome.
Pan F; Zhang T; Zhang YH; Xu JJ; Chen FM
Chin J Integr Med; 2009 Jun; 15(3):216-9. PubMed ID: 19568715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
